Hemostat clamp: Overview, Uses and Top Manufacturer Company

Introduction

Hemostat clamp is a foundational surgical medical device used to temporarily compress blood vessels or tissue to help control bleeding and support safe, efficient procedural work. It is one of the most frequently handled pieces of medical equipment in operating rooms (ORs), emergency care, obstetrics, and procedural suites—yet it is also a common source of preventable issues when selection, handling, counting, or reprocessing breaks down.

Although it looks “basic,” Hemostat clamp sits at the intersection of clinical technique and system reliability. A slightly worn ratchet, a jaw that no longer meets at the tip, or dried bioburden hidden in the box lock can turn a routine step into a safety event. In many procedures, multiple clamps may be placed quickly—sometimes dozens—so small differences in pattern, length, and jaw design can influence how easily the team maintains orientation, avoids tangling, and performs accurate counts.

This article explains Hemostat clamp from two angles: (1) how clinicians and trainees use it in real clinical workflows, and (2) how hospitals manage it as hospital equipment—including safety controls, training expectations, cleaning/sterilization, procurement considerations, and service/repair realities. You will also find a practical troubleshooting approach, an overview of manufacturer/OEM concepts, and a global market snapshot to help administrators and operations leaders understand demand drivers and supply ecosystem differences by country.

Because Hemostat clamp is ubiquitous, it is also a frequent target for standardization projects: tray rationalization, instrument tracking, repair contract optimization, and sterile processing quality improvement. Even modest improvements—such as consistent naming, improved inspection lighting, or a better method to stage clamps on the field—can reduce delays, prevent injuries, and lower the risk of retained items.

All content is general and educational. Always follow your facility policies, supervision requirements, and the manufacturer’s instructions for use (IFU).

What is Hemostat clamp and why do we use it?

Definition and purpose (plain language)

Hemostat clamp is a hand-held, mechanical clamping instrument—often called a “hemostat” or “hemostatic forceps”—designed to grasp and compress vessels or tissue so bleeding can be controlled long enough to complete a procedural step (for example, tying a ligature, placing a clip, or improving visualization). Unlike powered hemostasis tools, Hemostat clamp relies on simple leverage and a locking mechanism.

In many settings you may also hear the term “artery forceps” used generically for a hemostat-style clamp. Terminology varies by country, specialty, and training tradition, so teams benefit from agreeing on local naming conventions—especially when multiple sizes are present on the same tray.

In most settings it is treated as a critical clinical device because it contacts sterile tissue and blood, and therefore requires validated cleaning and sterilization when reusable.

Materials, finishes, and design features (why hospitals care)

While clinicians often focus on “does it hold,” hospitals must also consider how materials and finish affect reprocessing success, corrosion risk, and instrument lifespan. Common real-world considerations include:

• Material: many reusable clamps are made from surgical-grade stainless steels chosen for strength, corrosion resistance, and the ability to hold precise jaw alignment over repeated cycles. Material selection influences edge/serration wear and how the instrument tolerates detergents, water quality, and steam exposure over time.
• Surface finish: matte/satin finishes can reduce glare under OR lights, while highly polished finishes may show scratches more readily. Finish can also influence how easily soil is detected during inspection.
• Coatings and markings: some clamps may include black or colored coatings/finishes in specific surgical contexts (for example, to reduce reflections). Any coating introduces extra compatibility questions for cleaning chemistry and abrasion; the IFU becomes especially important.
• Length and profile: longer clamps improve reach in deeper fields but can create more lever effect on tissue if allowed to hang unsupported. Shorter clamps may be safer for superficial work and fine dissection.
• Jaw geometry: jaw taper, serration style, and curvature determine bite security and tissue trauma risk. Two clamps that look similar at a glance can behave very differently on the same vessel.
• Reusable vs. disposable: disposable (single-use) hemostats exist in some markets and kits. They may reduce reprocessing burden but can introduce differences in tactile feel, locking performance, and waste management. Facilities often evaluate them differently depending on case volume, staffing, and sterilization capacity.

Where it is commonly used

You may see Hemostat clamp in:

• Operating rooms (general surgery, obstetrics and gynecology, orthopedics, ENT, urology, plastics, and many others)
• Emergency departments (laceration management, bedside procedures under appropriate conditions)
• Labor and delivery (common in surgical instrument sets)
• Ambulatory surgery centers and procedure rooms
• Dental and outpatient procedural practices (varies by local scope and protocols)

In addition, Hemostat clamp often appears in minor procedure trays (for example, incision and drainage sets) and in specialty packs where it supports exposure, suture management, or temporary control of small bleeders. Even in minimally invasive workflows, hemostats may still be used for open steps such as skin closure, managing small bleeders at port sites, or organizing sutures on the sterile field.

How it works (mechanism of action)

Most Hemostat clamp designs share core parts:

• Ring handles (like scissors) for controlled grip
• Shanks that transmit force
• A box lock (hinge) that aligns the jaws
• Jaws with serrations (and sometimes teeth, depending on the type)
• A ratchet lock that holds the clamp closed at incremental “clicks”

The mechanism is purely mechanical:

1. The user positions the jaws around a target structure.
2. Closing the handles increases jaw compression.
3. Engaging the ratchet maintains that compression hands-free until the clamp is released.

There is no electronic feedback, alarm, or measurement. The “result” is assessed clinically (for example, whether bleeding stops and whether surrounding tissue is protected).

From an engineering perspective, small details matter: the condition of the box lock and the precision of the jaw alignment determine whether compression is evenly distributed. If the hinge is stiff from residue or corrosion, the user may apply extra force without realizing it. If the ratchet teeth are worn, the clamp may “creep” open under tension and lose hemostasis at an unsafe moment.

Key benefits for patient care and workflow

Hemostat clamp supports both clinical and operational goals:

• Rapid temporary hemostasis to reduce field contamination and improve visibility
• Hands-free holding once locked, enabling the operator to perform the next step
• Versatility (grasping, blunt dissection assistance, holding suture ends, stabilizing small structures)
• Standardization: widely recognized instrument types support teamwork, tray building, and training
• Durability and reusability (for reusable models) with repair/maintenance pathways in many regions

Additional workflow advantages that matter in practice include:

• No dependence on power or consumables: unlike energy devices or clip systems, a clamp works immediately without equipment setup, batteries, or disposable reloads.
• Predictable tactile feedback: experienced clinicians often rely on the “feel” of the ratchet and tissue response, which can be valuable when speed matters.
• Utility in resource-limited settings: where advanced hemostasis tools may be unavailable, well-maintained clamps and ligatures remain essential.

Common types and naming (why it matters)

You will hear names such as “mosquito,” “Kelly,” “Crile,” “Kocher,” “Rochester,” or “Carmalt.” These names often reflect jaw length, curvature, serration patterns, and intended tissue handling. Availability and naming can vary by manufacturer and training tradition. The key operational point is to match clamp size, jaw design, and expected holding strength to the clinical task and tissue characteristics.

To make naming more practical for teams, it helps to understand the usual “functional differences” behind common patterns (examples; exact dimensions vary):

• Mosquito (often Halsted mosquito): small and fine for delicate work and small vessels; common in superficial fields and pediatrics.
• Kelly: medium size; often has serrations on part of the jaw length (pattern-dependent), used for general hemostasis.
• Crile: similar general-purpose role; often has serrations that extend further along the jaw (pattern-dependent), offering more consistent grip along the full bite.
• Kocher (often Ochsner-Kocher): includes a tooth at the tip (pattern-dependent) for a more traumatic, secure hold on tough tissue (for example, fascia) rather than delicate vessels.
• Rochester-Pean: larger, heavier clamp for thicker tissue bundles and stronger holding requirements.
• Rochester-Carmalt: distinctive longitudinal serrations (often with cross-serrations at the tip), frequently used for clamping pedicles and larger tissue bundles where slip resistance is important.
• Right-angle (often Mixter): designed to pass ligatures around structures in deeper or narrower spaces; frequently used for vessel loop or tie passage rather than direct surface clamping.

Facilities often discover that “we all say ‘Kelly’” but mean different things. Standardized pick lists, instrument photos in tray documentation, and consistent labeling in sterile processing can reduce confusion—especially for float staff, travelers, and learners.

How medical students encounter Hemostat clamp in training

Most learners meet Hemostat clamp early:

• Anatomy or skills labs (instrument identification, handling drills)
• Basic suturing practice (using a clamp to hold suture ends or stabilize tissue models)
• OR orientation (safe passing, sterile field etiquette, instrument counts)
• Simulation scenarios (bleeding control steps and team communication)

For trainees, Hemostat clamp is also a “team instrument”: it is frequently passed, placed, and removed in quick sequences—making naming clarity, standardized sets, and disciplined counting essential.

Common early learning points include how to unlock smoothly without jerking, how to avoid clamping unintended tissue in a crowded field, and how to recognize the difference between a clamp that is appropriately engaged versus one that is over-tightened and likely to crush tissue.

When should I use Hemostat clamp (and when should I not)?

Appropriate use cases (general)

Clinicians commonly use Hemostat clamp for:

• Temporary control of bleeding from small vessels during open procedures
• Holding a vessel or tissue bundle to enable ligation or clip placement
• Securing a “bleeder” long enough to improve visualization and coordinate next steps
• Assisting blunt dissection by gently spreading along tissue planes (technique-dependent)
• Holding suture ends, small sponges, or stay sutures during a step (facility practice varies)
• Clamping soft tubing temporarily only when the tubing and procedure permit it and local protocol allows (many facilities prefer purpose-built clamps for lines and drains)

In short: Hemostat clamp is often used as a temporary, controlled “third hand” for hemostasis and tissue management.

Across specialties, typical scenarios include controlling small subcutaneous bleeders during incision closure, securing small mesenteric or soft tissue vessels before a tie is placed, and maintaining tension on a structure during exposure. In obstetrics and gynecology, clamps are commonly part of the workflow for temporarily controlling tissue bundles (often called pedicles) until suture ligation is completed—always under the clinical judgment and technique standards of the operating team.

When it may not be suitable

Hemostat clamp may be a poor choice when:

• The target structure is uncertain (for example, an unidentified structure in a deep field)
• The tissue is highly delicate or at risk of crush injury (use the least traumatic option available)
• A definitive vascular control method is required (strategy depends on procedure, anatomy, and clinician judgment)
• The clamp’s size or jaw pattern is mismatched to the task (risk of slipping or excessive trauma)
• A clamp is damaged, misaligned, loose, corroded, or difficult to clean
• Sterility is not assured for an invasive use (for reusable devices, sterility depends on validated reprocessing)

Additional “not ideal” situations often involve structures that should not be crushed (for example, nerves, ducts, or delicate tubes) and situations where a purpose-built alternative provides safer control (for example, specific vascular clamps, atraumatic graspers, or dedicated line clamps). Even when a clamp seems to “work,” the downstream consequence—tissue ischemia, tearing, or postoperative bleeding—may not be acceptable for the structure involved.

Safety cautions and contraindication-style considerations (non-prescriptive)

General risks to consider include:

• Tissue trauma from excessive pressure or prolonged clamping
• Slippage leading to re-bleeding or sudden movement in the field
• Unintended capture of adjacent structures due to poor visibility or crowding
• Instrument failure (ratchet not holding, hinge stiffness, jaw misalignment)
• Sharps and hand injuries during passing, locking/unlocking, or when clamps are left open on a tray edge

There are no universal “one-size-fits-all” contraindications because appropriate use depends on procedure, anatomy, and local practice. In training environments, use should be supervised and aligned with institutional protocols.

A practical mindset is to treat every clamp placement as a deliberate intervention: what structure is being clamped, what is the intended next step (tie, clip, cautery, exposure), and what is the plan for reassessment after release.

Clinical judgment and local protocols

Hemostat clamp is simple in design but not “risk-free.” The safest use depends on:

• Correct instrument selection
• Team communication (especially in a crowded operative field)
• A standardized approach to counts, placement, and removal
• Local infection prevention rules and reprocessing capacity
• Manufacturer IFU details (materials, lubrication compatibility, sterilization compatibility)

What do I need before starting?

Setup and environment

Before Hemostat clamp is used in a procedure, teams typically ensure:

• A prepared sterile field and appropriate instrument set (open surgery tray, minor procedure tray, specialty set)
• Adequate lighting and exposure for clear identification of structures
• A plan for hemostasis escalation (for example, sutures/ligatures, clips, topical hemostatic agents, suction, electrosurgery—varies by procedure)
• Safe staging on a Mayo stand or instrument table to reduce drops and confusion

For bedside or urgent settings, ensure the environment supports aseptic technique to the level required by local policy and the invasiveness of the procedure.

In high-volume rooms, teams may also plan how clamps will be organized spatially (for example, grouping similar clamps together, using a clamp stand/rack, or aligning handles in the same direction). Small workflow choices like this can reduce tangling, speed up identification, and lower the chance that a clamp disappears under sponges or drapes.

Accessories and supporting items (typical, not exhaustive)

Hemostat clamp is usually used alongside:

• Needle holders, forceps, scissors
• Suture materials or ligature ties
• Suction and gauze/sponges (with count processes when applicable)
• Sterile basins and packaging/indicator materials (reprocessing dependent)

Depending on procedure and preference, supporting items may also include vessel loops, hemostatic clips/clip appliers, topical hemostatic materials, and retractors that improve exposure so clamping can be more precise. From an operational standpoint, having a reliable “next step” ready (tie, clip, or definitive method) reduces the temptation to leave clamps on tissue longer than necessary.

Training and competency expectations

Competency is not only “how to clamp,” but also:

• Instrument identification (straight vs curved, jaw patterns, sizes)
• Safe passing and receiving (closed vs open passing rules vary)
• Recognizing defects (misalignment, ratchet failure, corrosion, debris in serrations)
• Understanding when to escalate to a different tool or technique
• Following sterile processing and count policies

For residents and students, supervised practice and skills lab repetition matter because the instrument is frequently used under time pressure.

Many facilities formalize this into a skills checklist: correct grip, controlled ratchet engagement, controlled release, and appropriate communication (“clamp on the bleeder,” “two mosquitoes on the superficial vessel,” etc.). For sterile processing staff, competency often includes recognizing jaw wear patterns, checking for staining or pitting, and understanding when an instrument should be repaired versus removed from service.

Pre-use checks and documentation

Common pre-use checks include:

• Jaw alignment (tips meet appropriately; no obvious gaps or crossing)
• Ratchet function (engages smoothly; releases without sticking)
• Box lock cleanliness (no visible debris; smooth movement)
• Surface integrity (no rust, pitting, cracks, or peeling finish)
• Confirmation of sterile status (indicator checks per facility practice)

Additional quick checks that help catch subtle problems include:

• Smooth opening/closing through full range: grinding, “catching,” or uneven resistance can indicate residue, corrosion, or hinge distortion.
• Tip integrity: bent tips or burrs may be hard to see without good lighting but can tear tissue and gloves.
• Jaw symmetry under light: holding the jaws up to bright light can reveal gaps that reduce holding reliability (a common reason for slippage).

Documentation varies, but hospitals often track:

• Tray/set completeness
• Sterilization load/lot traceability
• Instrument repairs and removals from service
• Incident reports for failures, suspected contamination, or count discrepancies

Operational prerequisites (for administrators and operations leaders)

Because Hemostat clamp is often reusable, operational readiness includes:

• A validated reprocessing pathway (cleaning, inspection, packaging, sterilization, storage)
• A repair/refurbishment process (internal or external) and clear criteria for retirement
• Standardized sets to reduce variation and staff confusion
• Policies on single-use vs reusable instruments (varies by manufacturer labeling and local regulation)
• Procurement controls to reduce counterfeit/substandard instruments and ensure IFU access

Operational leaders may also consider:

• Instrument tracking systems (barcode/RFID where implemented) to connect clamps to sets, repairs, and sterilization loads.
• Tray optimization programs to remove unnecessary duplicates that increase count complexity while ensuring enough clamps are available for peak case demand.
• Water and steam quality management in sterile processing, since poor water quality can accelerate staining and corrosion, increasing replacement and repair costs.

Roles and responsibilities (who does what)

• Clinicians: select and use the appropriate clamp, communicate critical placements, and report functional problems.
• Perioperative nursing/scrub staff: prepare sets, manage passing, maintain counts, and isolate defective instruments.
• Sterile processing/CSSD: clean, inspect, lubricate if applicable, package, sterilize, and document reprocessing outcomes.
• Biomedical engineering/clinical engineering: may support device inventory systems, incident investigations, and vendor coordination; involvement varies by hospital.
• Procurement/supply chain: vendor qualification, contract management, standardization decisions, and cost-of-ownership analysis (including repair and reprocessing impact).

Depending on the facility, infection prevention and quality/risk management teams may also play a direct role when instrument-related incidents occur (for example, reprocessing failures, unusual staining/corrosion trends, or count discrepancies). Clear handoffs between OR, sterile processing, and supply chain make it easier to quarantine suspect instruments quickly and prevent repeat use.

How do I use it correctly (basic operation)?

Hemostat clamp use is technique-dependent and should be learned under supervision. Workflows vary by specialty and facility, but the following steps are widely applicable.

Basic step-by-step workflow (common elements)

1. Select the appropriate Hemostat clamp based on size, curvature (straight/curved), and jaw pattern for the task.
2. Confirm integrity and sterility before it enters the sterile field and before use.
3. Hold the instrument correctly using the ring handles for control; avoid gripping so tightly that fine movements are lost.
4. Approach the target with clear visualization and minimal tissue crowding.
5. Place the jaws intentionally around the intended structure only.
6. Close to the minimal effective ratchet position needed to achieve the intended hold.
7. Confirm the immediate effect (for example, bleeding control, stable grasp, improved exposure).
8. Communicate placement when the clamp is near critical anatomy or when multiple clamps are in the field.
9. Proceed with the next step (ligation, clip placement, dissection, or exposure) as appropriate to the procedure.
10. Release carefully by disengaging the ratchet and opening the jaws in a controlled manner.
11. Reassess the field after removal for ongoing bleeding or tissue injury.

In many teams, the “micro-skills” that distinguish safe clamp use include: keeping the clamp oriented so it does not pull on tissue, placing it so the surgeon can easily see and retrieve it, and unlocking it without twisting the jaws. A controlled release is especially important—rapid opening can tear tissue or allow a vessel to retract, making definitive control harder.

Setup and calibration (what applies and what doesn’t)

Hemostat clamp generally does not require calibration in the way electronic medical equipment does. Instead, safety depends on:

• Functional checks (ratchet engagement/release, hinge smoothness)
• Visual inspection (alignment, surface integrity)
• Cleanliness and sterility confirmation
• Correct selection for the tissue/task

That said, some repair services and instrument maintenance programs perform tension and alignment checks using simple gauges or standardized tests. These are not “calibration” in the electronic sense, but they help ensure the instrument still performs within expected mechanical behavior after many reprocessing cycles.

“Settings” and what they mean (ratchet positions)

While Hemostat clamp has no numeric settings, the ratchet provides incremental locking positions. In general terms:

• Earlier ratchet positions apply less compression than later positions.
• The actual force depends on instrument size, design, wear, hand strength, and tissue thickness (varies by manufacturer and condition).
• A common safety principle is to use the least force necessary for the intended temporary hold.

In practice, teams often develop muscle memory for what “first click” or “second click” typically feels like on their instrument set. When new clamps are introduced, the “feel” may change, which is one reason standardization and controlled purchasing can improve safety and reduce tissue trauma.

Steps that are commonly universal

Across models and brands, the universal safety steps include:

• Don’t clamp what you can’t see or confidently identify.
• Avoid using damaged or hard-to-clean instruments.
• Keep clamps organized in the field to support reliable counts and safe removal.
• Unlock and remove with control—avoid sudden release that can tear tissue or trigger re-bleeding.
• Treat Hemostat clamp as sharps-adjacent: its tips and serrations can injure tissue and hands.

Additional universally helpful habits include keeping clamps off the very edge of the Mayo stand (to prevent falls and sterility breaks) and avoiding “stacking” multiple clamps in a way that interlocks ratchets, which can delay release when speed matters.

How do I keep the patient safe?

Patient safety with Hemostat clamp is primarily about tissue protection, hemostasis reliability, infection prevention, and human factors.

Core safety practices

• Match the clamp to the task: small, delicate work often calls for smaller, less traumatic jaws; heavier tissue may require a different pattern.
• Use minimal necessary pressure: more force is not automatically safer and can increase tissue trauma.
• Maintain visualization: avoid blind placement, especially in deep or crowded fields.
• Limit unintended traction: a locked clamp can act as a lever; manage where it rests to avoid pulling on tissue.
• Reassess after release: temporary control can mask ongoing bleeding until the clamp is removed.
• Keep the sterile field organized: reduce misplacement, drops, and retention risk.

A practical time-related consideration is duration of clamping. Prolonged compression can increase crush injury risk and may complicate later hemostasis when tissue becomes friable. Teams commonly aim to transition from “temporary clamp” to “definitive control” (tie/clip/seal) promptly, consistent with the procedure and the clinician’s plan.

Human factors: communication and teamwork

Hemostat clamp is used fast and often in multiples. Safety improves when teams:

• Use consistent instrument names (and clarify local naming differences)
• Announce placement on critical structures when relevant
• Avoid piling clamps where tips and locks tangle (risk of contamination, sharps injury, and count errors)
• Maintain an environment where staff can speak up about defects or concerns

In busy cases, it can help to adopt simple conventions: aligning clamp handles in one direction, grouping similar clamps, and verbally confirming when a clamp is intentionally left in place for a later step. These small behaviors reduce cognitive load and make it easier for relief staff to understand what is in the field.

“Alarm handling” in a non-alarming device

Hemostat clamp has no electronic alarms. The functional equivalents are visual and tactile cues:

• Ratchet that feels uneven or doesn’t hold
• Jaws that appear misaligned or don’t meet
• Tissue blanching, tearing, or unexpected bleeding patterns
• Clamps slipping, rotating, or “walking” off tissue

Facilities can reduce risk through checklists, standardized trays, and a culture of immediate instrument removal from service when defects are noticed.

Another useful cue is the sound and feel of the ratchet “click.” Experienced staff often notice when a ratchet suddenly sounds softer, skips, or requires unusual force—often an early sign of wear or contamination in the lock teeth.

Risk controls that administrators should care about

• Label and traceability checks for sets and reprocessing loads
• Clear policies on single-use instruments (do not reprocess if labeled single-use)
• Routine inspection criteria and repair pathways
• Vendor qualification to reduce counterfeit or inconsistent-quality instruments
• Incident reporting and learning systems (near-misses matter with basic instruments)

Administrators may also prioritize controls that reduce retained-item risk:

• Strong count policy adherence for instruments, including clamps
• Clear processes for count discrepancies (search sequence, imaging triggers where applicable, documentation expectations)
• Tray design that avoids unnecessary clamp duplication while still meeting clinical needs

Incident reporting culture (general)

If Hemostat clamp contributes to harm or a near-miss (slippage, breakage, suspected contamination, count issue), reporting should be:

• Timely and non-punitive
• Specific (instrument type, set, lot/asset ID if available, what happened, where in workflow)
• Linked to corrective actions (repair, staff training, tray redesign, vendor escalation)

In instrument-related events, photos of the defect (when permitted by policy), retention of the instrument for evaluation, and rapid communication between OR and sterile processing can accelerate root-cause analysis and prevent recurrence.

How do I interpret the output?

Hemostat clamp does not generate numeric data. Its “output” is the observed mechanical behavior and clinical effect.

Types of outputs you can observe

• Mechanical output: ratchet engagement strength, smoothness of hinge movement, stability of grip, ease of release.
• Clinical effect output: reduced or stopped bleeding, improved visualization, stable tissue control, absence of slippage.
• Tissue response output: indentation marks, blanching, tearing, or unexpected bleeding after release.

A subtle but important “output” is how the clamp behaves under traction. A clamp that holds when stationary may slip when the tissue is moved or when a suture is tied. Observing whether the clamp rotates, migrates, or loosens during manipulation helps clinicians decide whether to reposition, upsize, or switch to a different tool.

How clinicians typically interpret results

Clinicians generally interpret Hemostat clamp effectiveness by asking:

• Did bleeding stop or significantly reduce?
• Is the structure securely held without tearing?
• Does the clamp stay in position without drifting?
• After release, is hemostasis maintained or does bleeding recur?

Because the device is temporary, “success” often includes what happens after the clamp is removed and definitive control is established.

Clinically, bleeding patterns can also guide interpretation: persistent pulsatile bleeding, brisk flow, or bleeding that resumes immediately after release may indicate that a clamp alone is insufficient and that a different approach is needed (based on clinical judgment and the procedure’s hemostasis plan).

Common pitfalls and limitations

• False reassurance: temporary cessation can be due to spasm or transient low flow; bleeding can recur.
• Hidden bleeding: clamp placement can obscure the source, especially when multiple clamps are present.
• Over-compression: tissue injury may not be obvious until later steps.
• Assuming ratchet position equals safe force: force varies with instrument condition and tissue thickness (varies by manufacturer and wear).
• Using the wrong clamp pattern: a clamp designed for traumatic holding may injure delicate tissue.

The key principle is clinical correlation: Hemostat clamp is an instrument, not a diagnostic tool, and it cannot “confirm” definitive hemostasis by itself.

What if something goes wrong?

When problems occur, prioritize safety, stop escalation of harm, and follow local protocols.

Troubleshooting checklist (practical and general)

• Bleeding continues despite clamping: reassess placement and visualization; consider additional exposure, a second clamp, or an alternate hemostasis method per supervision and protocol.
• Clamp slips off tissue: check for tissue thickness mismatch, inadequate jaw purchase, fluid contamination on jaws, or incorrect instrument choice.
• Ratchet won’t lock or pops open: remove from use, replace immediately, and tag for inspection/repair.
• Ratchet won’t release: avoid forceful twisting; stabilize and disengage carefully; if persistent, replace and send for service evaluation.
• Jaws misaligned or tips crossed: do not use; isolate for repair/retirement.
• Visible debris in serrations/box lock: treat as reprocessing failure; remove from the sterile field and replace.
• Instrument dropped or sterility compromised: remove and replace per sterile field policy.
• Instrument breaks: stop and account for all fragments; isolate the set; escalate through risk management and service channels.

Additional operational troubleshooting patterns include:

• Hinge feels stiff in the OR: this can indicate residual soil, inadequate lubrication (if used/allowed), or corrosion. Replace the instrument rather than forcing it, and notify sterile processing so they can investigate washer parameters and inspection practices.
• Brown/orange staining noted repeatedly: recurring staining may point to water quality issues, chemistry incompatibility, or inadequate drying. Even if a stain can be removed, repeated staining is a signal to review process controls.

When to stop use immediately

Stop using Hemostat clamp if:

• Sterility is uncertain for an invasive use
• Mechanical integrity is compromised (cracks, loose hinge, ratchet failure)
• Cleaning failures are evident
• The instrument is suspected to have contributed to an adverse event

When to escalate to biomedical engineering or the manufacturer

Escalation is appropriate when:

• Multiple clamps from the same batch show repeat failures
• There is unexplained corrosion, coating failure, or unusual wear
• Repairs are frequent and cost/benefit needs reassessment
• There is a suspected manufacturing defect or labeling/IFU concern

Include any available identifiers (set name, asset tag, reprocessing load info, purchase details). Reporting pathways vary by country and facility.

From a systems perspective, repeated clamp problems can also signal workflow damage points: clamps being thrown into bins, stacked under heavy retractors, or processed in a way that stresses the box lock. Escalation is not only about blaming the device—it is about finding the correct fix (training, transport changes, repair frequency, or vendor selection).

Documentation and safety reporting expectations (general)

• Record the event in the facility’s incident reporting system.
• Ensure the instrument is removed from circulation until evaluated.
• Communicate with sterile processing and supply chain to prevent recurrence (set redesign, vendor engagement, training refresh).

Infection control and cleaning of Hemostat clamp

Hemostat clamp is typically a reusable surgical instrument that contacts blood and sterile tissue, so it generally requires validated cleaning and sterilization. Exact methods depend on the manufacturer IFU and local infection prevention policy.

Cleaning principles (what “good” looks like)

• Point-of-use care: prevent soil from drying; keep instruments appropriately moist per facility practice.
• Thorough cleaning before sterilization: sterilization is not a substitute for cleaning.
• Attention to hard-to-clean areas: box lock, serrations, and ratchet.
• Inspection after cleaning: cleanliness is verified before packaging and sterilization.
• Separation of damaged instruments: defects can trap soil and compromise sterility.

A key quality concept is that “clean” is not just visual. Facilities increasingly use enhanced verification (for example, magnified inspection, protein residue tests, or other process checks) to ensure that hard-to-clean instrument geometries are consistently addressed—even when the instrument looks clean to the naked eye.

Disinfection vs. sterilization (plain-language distinction)

• Disinfection reduces microorganisms but may not eliminate all spores.
• Sterilization aims to eliminate all forms of microbial life, including spores.

Because Hemostat clamp is commonly used in sterile body sites, it is generally processed as a sterile instrument. The appropriate method (steam or low-temperature processes) depends on materials and IFU (varies by manufacturer).

High-risk/high-touch areas on the instrument

• Jaw serrations (retain bioburden)
• Box lock (hidden surfaces)
• Ratchet teeth (soil traps)
• Ring handles and shanks (handling contamination)

These zones are also the places where corrosion and staining are most likely to develop if moisture is retained or if chemicals are incompatible. Paying attention to these areas during inspection improves both infection prevention and device longevity.

Example reprocessing workflow (non-brand-specific)

1. At point of use: wipe gross soil; keep instrument open; segregate from delicate instruments as appropriate.
2. Transport: closed container to decontamination area.
3. Cleaning: manual brushing of serrations and hinge + mechanical cleaning (for example, ultrasonic) per facility process.
4. Rinse and dry: thorough rinsing and complete drying to reduce residue and corrosion risk.
5. Inspect and function-check: alignment, ratchet, hinge motion, cleanliness under good lighting/magnification.
6. Lubricate if allowed: only if compatible with IFU and facility policy.
7. Package: often sterilized in an open/unlocked position to allow sterilant contact (facility practice varies).
8. Sterilize and store: per validated cycle and storage conditions; maintain traceability.

Two practical reprocessing details frequently affect clamp performance:

• Drying quality: residual moisture trapped in the box lock can drive spotting, pitting, and stiffness over time. Drying steps and storage humidity control matter.
• Chemistry and water quality: harsh chemicals (including inappropriate chlorine exposure) or mineral-heavy water can accelerate corrosion and cause staining that looks like “rust.” Facilities often address this through detergent selection, correct dilution, and water treatment aligned with their sterile processing standards.

Single-use instruments

If a Hemostat clamp is labeled single-use, do not reprocess it unless allowed by local regulation and an approved reprocessing program. Policies and legality vary significantly by country and facility.

Operationally, facilities may choose single-use clamps in specific contexts (for example, procedure kits where reprocessing capacity is constrained). However, single-use selection should include a realistic evaluation of performance consistency, waste handling, and the total cost impact compared with a durable reusable clamp supported by a solid reprocessing and repair pathway.

Medical Device Companies & OEMs

Manufacturer vs. OEM (Original Equipment Manufacturer)

A manufacturer is the entity responsible for designing and/or producing a medical device and providing labeling and IFU under their name. An OEM (Original Equipment Manufacturer) may produce the instrument that another company sells under its own brand (private label). In global supply chains, Hemostat clamp products may be made by one party and branded/marketed by another.

In practice, the “name on the box” and the “entity that machined and finished the instrument” may be different. For sterile processing, the most important output of this relationship is consistent access to the correct IFU and a clear path to quality support when defects or compatibility questions arise.

Why OEM relationships matter for Hemostat clamp

OEM relationships can affect:

• Consistency of materials and finishing (varies by manufacturer)
• Access to IFU details critical for cleaning and sterilization compatibility
• Warranty and repair pathways
• Traceability for recalls, quality events, or adverse incident investigations
• Standardization decisions across instrument sets

For procurement and sterile processing leaders, clarifying who actually makes the device (and who is responsible for IFU and support) reduces operational surprises.

A practical procurement approach is to ask: If we have a problem (corrosion trend, ratchet failures, alignment issues), who will investigate, and what evidence will they require (photos, lot numbers, purchase records, reprocessing parameters)? The clarity of that answer often differentiates mature suppliers from opportunistic sellers.

Top 5 World Best Medical Device Companies / Manufacturers

The following are example industry leaders (not a ranking). Whether any specific company offers Hemostat clamp in your market depends on portfolio, region, and distributor arrangements (varies by manufacturer).

1. Johnson & Johnson (Ethicon and related businesses)
   Known globally for broad surgical and medical products, including wound closure and operating room consumables. The organization has a long footprint in perioperative workflows, training, and product standardization. Hemostat clamp availability under this corporate umbrella varies by region and product line. Support and contracting are typically handled through established hospital procurement channels.

2. Medtronic
   A global medical technology company with a strong presence in surgical technologies and procedural care categories. Many hospitals interact with Medtronic through OR integration, specialty devices, and capital equipment pathways, depending on local procurement strategy. Whether it supplies Hemostat clamp directly depends on market and portfolio (varies by manufacturer). Its scale influences service expectations, documentation, and vendor management processes.

3. B. Braun (including Aesculap in many markets)
   Widely recognized for surgical instruments, sterile processing-focused products, and perioperative consumables in numerous regions. Many facilities associate the brand with reusable instrument ecosystems and reprocessing compatibility documentation, though specific offerings vary. For Hemostat clamp procurement, buyers often evaluate instrument finish, repairability, and set standardization support. Local distributor arrangements and after-sales service differ by country.

4. Stryker
   A major operating room and surgical technology supplier with broad hospital relationships. Depending on the region, Stryker’s portfolio may include surgical instruments and OR equipment alongside specialty platforms. Hemostat clamp availability and the depth of reusable instrument lines vary (varies by manufacturer). Procurement teams often consider integration with existing OR workflows and service infrastructure.

5. Smith+Nephew
   A global company active in surgical and wound-related categories, with established hospital presence in many countries. Product focus and availability differ by region, and the extent of basic instrument offerings such as Hemostat clamp may vary by channel (varies by manufacturer). Facilities commonly interact with the company through surgical services, training, and distributor networks. As always, confirm IFU and reprocessing compatibility for any reusable instrument.

Vendors, Suppliers, and Distributors

Role differences: vendor vs. supplier vs. distributor

In hospital purchasing language:

• A vendor is any entity selling products or services to the facility (may be a manufacturer or a reseller).
• A supplier provides goods to meet demand; the term is often used broadly for contracted sources.
• A distributor stocks, transports, and delivers products, sometimes providing credit terms, kitting, and inventory management.

For Hemostat clamp, distributors can strongly influence lead times, set-building support, repair turnaround coordination, and availability of consistent instrument patterns across facilities.

Distributors may also support value-added services that affect clamp availability and standardization, such as tray kitting, labeling/asset tagging programs, and coordinating instrument repairs or exchanges. For multi-site health systems, distributor capability can determine whether one site ends up with a different “Kelly” pattern than another—creating training and safety variability.

Top 5 World Best Vendors / Suppliers / Distributors

The following are example global distributors (not a ranking). Availability and regional strength vary by country, and not all companies operate in every market.

1. McKesson
   A large healthcare distribution organization with wide reach in markets where it operates. Buyers often rely on such distributors for dependable fulfillment, contract purchasing support, and broad catalog access. For Hemostat clamp sourcing, distribution performance can affect OR readiness and backorder risk. Service scope depends on region and contracting model.

2. Cardinal Health
   A major healthcare services and distribution company in markets where it is active. Hospitals may use Cardinal Health for medical-surgical supply distribution, inventory programs, and consolidated purchasing. Hemostat clamp procurement through a large distributor can simplify ordering and standardization across sites. Exact portfolio and private-label availability vary by region.

3. Medline Industries
   Active as both a manufacturer and distributor in many countries, with strong presence in medical-surgical supplies. Facilities often interact with Medline for standardized products, logistics support, and large-scale supply programs. For Hemostat clamp, buyers may encounter both branded and private-label options depending on the market. Service offerings (kitting, inventory management) vary by country and contract.

4. Henry Schein
   Known for distribution into outpatient, dental, and office-based care settings, with presence in multiple regions. Depending on the country, Henry Schein may support clinics and ambulatory centers that purchase procedure supplies and instruments. Hemostat clamp availability may be oriented toward outpatient procedural needs and practice settings. Support models differ by geography and segment.

5. Owens & Minor
   A healthcare logistics and supply chain services organization in markets where it operates. Hospitals may use such distributors for medical-surgical distribution, logistics programs, and supply chain optimization support. Hemostat clamp procurement is often part of broader instrument and consumable purchasing strategies. Regional availability and service depth vary.

Global Market Snapshot by Country

India

Hemostat clamp demand in India is driven by high surgical volume across public hospitals, private multispecialty centers, and a large ambulatory sector. Many facilities rely on competitive sourcing across domestic manufacturers and imports, with strong emphasis on price, set standardization, and reprocessing compatibility. Urban tertiary centers typically have more mature sterile processing capacity than rural facilities, where instrument lifecycle control and repair access may be more variable.

A practical purchasing factor is the diversity of facility types: teaching hospitals may prioritize durable, repairable clamps that tolerate heavy use, while smaller centers may prioritize rapid availability. Standardization across large hospital chains can be challenging when sites have different legacy tray designs and reprocessing resources.

China

In China, Hemostat clamp demand tracks large hospital networks, expanding surgical services, and ongoing investment in healthcare infrastructure. Procurement commonly balances domestic production with imports, influenced by local purchasing policies and hospital tiering. Major cities tend to have robust distribution and sterile processing resources, while smaller facilities may prioritize cost and availability, affecting instrument standardization and service ecosystems.

Hospitals may also evaluate suppliers based on their ability to provide consistent patterns across many sites, along with documentation that supports audit expectations. For reusable clamps, access to repairs and predictable replacement lead times can be decisive in maintaining instrument readiness.

United States

The United States market is shaped by high procedural volume, strong regulatory and quality expectations, and mature sterile processing standards. Buyers frequently evaluate total cost of ownership, including instrument tracking, repair contracts, and tray optimization programs. There is also ongoing tension between single-use convenience and reusable sustainability goals, with purchasing decisions influenced by facility policy, reimbursement pressures, and infection prevention risk assessments.

Because staffing and turnaround time are persistent operational pressures, many facilities focus on instrument availability: having enough clamps to support schedule peaks without unsafe shortcuts. Standardization efforts often include reducing unnecessary clamp variation across service lines so that training, tray assembly, and inspection are more consistent.

Indonesia

Indonesia’s demand is concentrated in urban hospitals and private healthcare networks, with access differences across islands affecting supply reliability and service support. Import dependence can be significant for certain instrument quality tiers, while local distribution networks determine lead times and consistency. Facilities with constrained sterile processing capacity may prioritize simplified sets and durable instruments, but practices vary widely by region and hospital type.

Geographic logistics and variable procurement cycles can lead to mixed inventories, where different clamp brands coexist on the same tray. This makes inspection and performance consistency a practical concern for OR and sterile processing teams.

Pakistan

In Pakistan, Hemostat clamp procurement often reflects budget constraints in public facilities and a mix of domestic and imported supply in private hospitals. Service and repair ecosystems can be uneven, making durability and availability of replacements important operational considerations. Urban centers generally have better access to sterile processing resources and distributor support than rural hospitals, influencing instrument lifecycle management.

Pakistan is also known globally for surgical instrument manufacturing in certain regions, which can influence local availability and pricing. For buyers, the key differentiators often become finishing quality, consistency of jaw alignment, and clarity of reprocessing guidance.

Nigeria

Nigeria’s market is characterized by strong demand in large urban hospitals and private facilities, alongside significant access challenges in rural areas. Import dependence is common, and supply chain variability can affect consistency of instrument patterns and reprocessing documentation. Facilities may focus on instruments that tolerate repeated reprocessing cycles, while also managing constraints in sterile processing infrastructure and workforce training.

Where sterile processing resources are limited, practical design features—like smooth box locks, robust corrosion resistance, and easily inspected serrations—can be prioritized to support safer reuse and reduce hidden soil risk.

Brazil

Brazil has a sizable healthcare system with both public and private sectors driving consistent demand for surgical instruments including Hemostat clamp. Distribution and service ecosystems are more developed in major metropolitan regions, supporting instrument standardization and repair pathways. Procurement decisions can be influenced by tender processes, local manufacturing capacity, and hospital network consolidation, with variability in access between urban and remote areas.

In large networks, centralized purchasing can improve standardization, but it also increases the importance of selecting patterns that work across many surgeons and specialties. Repair turnaround and regional service coverage are practical differentiators.

Bangladesh

In Bangladesh, Hemostat clamp demand is supported by growing surgical services and a large population base. Many facilities rely on imports and distributor channels, with price sensitivity and availability playing major roles in purchasing. Sterile processing capacity varies, so hospitals often emphasize clear IFU access, training, and instrument sets that match their reprocessing realities.

Facilities may also need clamps that perform reliably despite frequent cycles and high utilization. In such environments, inspection discipline and repair access become central to maintaining safe instrument function.

Russia

Russia’s market includes large urban medical centers with established procurement systems and a wide geographic spread that can complicate distribution to remote regions. Import reliance may vary depending on local manufacturing and procurement policies, and availability can be influenced by trade and logistics constraints. Service ecosystems for reusable instruments tend to be stronger in major cities, affecting repair turnaround and standardization.

For remote sites, maintaining adequate spare inventory and selecting instruments that tolerate local sterilization conditions can reduce downtime. Standardization across regions can be difficult if supply routes vary.

Mexico

Mexico’s demand for Hemostat clamp reflects a mix of public system procurement and private hospital growth, especially in urban areas. Distributor networks play a major role in availability and after-sales support, including set building and replacement cycles. Differences in sterile processing maturity across facilities influence whether buyers prioritize premium reusable instruments, lower-cost options, or hybrid approaches.

Private hospitals may invest more heavily in standardized sets and repair contracts, while public procurement often depends on tender timing and budget cycles. These differences can lead to variability in instrument quality and lifecycle management.

Ethiopia

Ethiopia’s market is shaped by expanding surgical access initiatives, donor-supported programs in some settings, and the practical realities of supply chain and reprocessing capacity. Import dependence is common, and consistent access to repairs, replacement parts, and validated reprocessing supplies can be challenging outside major cities. Procurement often prioritizes durability, ease of cleaning, and compatibility with available sterilization methods.

In settings where steam sterilization is the dominant method, clamps that are easy to clean, resist corrosion, and remain aligned after repeated cycles are especially valuable. Training and simple inspection tools can have outsized impact.

Japan

Japan’s healthcare system supports high-quality surgical care with strong expectations for instrument performance and reprocessing discipline. Hospitals tend to emphasize standardized sets, reliable supplier relationships, and clear documentation for cleaning and sterilization compatibility. While access is generally strong, procurement decisions often reflect careful evaluation of quality, workflow efficiency, and long-term lifecycle considerations.

In many facilities, continuous improvement culture influences how instruments are managed—regular inspection, structured repairs, and detailed tray documentation support consistent performance and reduce variability across teams.

Philippines

In the Philippines, demand is concentrated in metropolitan hospitals and expanding private networks, with regional access differences affecting supply continuity. Import dependence is common, and distributor performance influences lead times and consistency across multisite systems. Sterile processing capacity and training can vary, making straightforward IFU, robust instrument construction, and practical repair options important to operations teams.

Hospitals with high turnover and mixed staffing often benefit from standardizing clamp patterns and naming to reduce confusion and shorten onboarding time for new personnel.

Egypt

Egypt’s market combines large public hospitals with a substantial private sector, both contributing to ongoing demand for Hemostat clamp and surgical sets. Import channels and local distribution networks influence availability and pricing, while major urban centers often have better access to service support. Reprocessing practices vary by facility, so procurement teams frequently consider instrument durability and the local sterilization environment.

In high-volume settings, clamps are exposed to heavy utilization and frequent cycles, making repairability and resistance to hinge stiffness important factors in total cost of ownership.

Democratic Republic of the Congo

In the Democratic Republic of the Congo, demand is closely tied to urban referral centers, humanitarian support in some areas, and the constraints of logistics and infrastructure. Import dependence and supply chain disruptions can affect continuity of instrument availability and consistency of set composition. Sterile processing capacity may be limited in some facilities, increasing the importance of training, simple designs, and reliable sterilization compatibility.

Where replacement lead times are long, preventive maintenance habits—careful transport, minimizing damage, and disciplined inspection—can be critical to sustaining surgical capacity.

Vietnam

Vietnam’s healthcare landscape includes rapidly developing urban hospitals and growing surgical capacity, driving steady demand for basic surgical instruments. Procurement often blends domestic supply with imports, influenced by cost, quality expectations, and distributor relationships. Urban centers typically have stronger sterile processing ecosystems, while smaller hospitals may face tighter constraints on reprocessing resources and repair access.

As facilities modernize, standardization and documentation (including IFU availability) become more important, especially when hospitals seek to align practice across expanding networks.

Iran

Iran’s market reflects a mix of local manufacturing capability and import sourcing depending on product category and availability. Hospitals in major cities generally have more robust procurement and reprocessing infrastructure than smaller facilities, which can affect standardization and lifecycle management. Supply continuity and service support can be key considerations for reusable Hemostat clamp purchasing decisions.

Facilities may prioritize suppliers who can provide consistent quality and clear reprocessing guidance that aligns with local sterilization methods and available detergents.

Turkey

Turkey serves a large domestic healthcare market and often functions as a regional hub for medical services and distribution. Demand for Hemostat clamp is driven by high procedure volumes and a broad network of public and private hospitals. Procurement decisions commonly weigh quality, pricing, and availability of support services, with urban facilities typically better positioned for standardized reprocessing and repair workflows.

In large private centers, workflow efficiency and instrument set optimization can strongly influence purchasing, with emphasis on consistency and rapid turnaround for repairs.

Germany

Germany’s market emphasizes quality systems, standardized sterile processing, and documentation-driven procurement processes. Hospitals often evaluate Hemostat clamp within broader instrument set optimization, focusing on reliability, repairability, and reprocessing compatibility. Distribution and service ecosystems are generally mature, supporting consistent access across regions, though purchasing decisions remain sensitive to hospital budgets and contracting structures.

Germany also has a long tradition of surgical instrument manufacturing and repair services, which supports robust lifecycle management and availability of technical expertise for refurbishment.

Thailand

Thailand’s demand is supported by major urban hospitals, a strong private healthcare sector, and broad surgical service provision. Import dependence varies, and distributor networks strongly influence availability and after-sales support for reusable instruments. Differences between urban and rural facility capacity—especially for sterile processing and instrument maintenance—shape purchasing priorities and standardization efforts.

Private hospitals that serve international patients may place added emphasis on standardized sets, appearance/finish consistency, and documented reprocessing compatibility to meet internal quality expectations.

Key Takeaways and Practical Checklist for Hemostat clamp

• Treat Hemostat clamp as a critical instrument that affects hemostasis and workflow.
• Confirm sterility status before invasive use and follow local aseptic protocols.
• Select clamp size and jaw pattern to match tissue fragility and task demands.
• Use the least ratchet force that achieves a stable, intended hold.
• Avoid blind clamping when anatomy or visibility is uncertain.
• Reassess the field after release; temporary control can mask ongoing bleeding.
• Keep the operative field organized so multiple clamps do not tangle or obscure visibility.
• Standardize naming (mosquito vs Kelly vs other) within teams to reduce errors.
• Do a quick functional check: jaws align, ratchet holds, ratchet releases smoothly.
• Remove from service any clamp with corrosion, pitting, cracks, or loose hinges.
• Don’t “make do” with a damaged clamp; replace it immediately.
• Build tray sets based on real procedure needs to reduce clutter and count risk.
• Ensure instrument counts include clamps and follow your facility’s counting policy.
• Avoid using Hemostat clamp as a substitute for purpose-built line or tube clamps.
• Communicate clearly when a clamp is placed near critical structures.
• Treat clamp tips as injury hazards during passing and staging on the table.
• Store and transport clamps to prevent tip damage and jaw misalignment.
• Include Hemostat clamp in routine inspection and preventive maintenance programs.
• Maintain traceability for sets and sterilization loads where systems exist.
• Train students and new staff on both technique and instrument safety culture.
• Make reprocessing easy: open/unlock for cleaning and ensure hinge access.
• Focus cleaning on serrations, box lock, and ratchet where soil can hide.
• Verify cleanliness before sterilization; sterilization does not replace cleaning.
• Follow manufacturer IFU for cleaning agents, lubrication, and sterilization method.
• Do not reprocess a single-use Hemostat clamp unless permitted by policy and law.
• Track repair frequency to identify low-quality supply or workflow damage points.
• Engage procurement, OR, and sterile processing together for instrument standardization.
• Use incident reports to drive tray redesign, training refreshers, and vendor escalation.
• Escalate repeated failures to biomedical engineering/clinical engineering as appropriate.
• Require vendors to provide IFU access and support for reprocessing compatibility questions.
• Evaluate total cost of ownership, not just unit price, for reusable instruments.
• Consider local sterilization capacity when choosing materials and finishes.
• In resource-limited settings, prioritize robust designs that tolerate validated reprocessing.
• Avoid mixing inconsistent clamp patterns in one set unless clinically justified.
• Keep spare clamps available for high-volume areas to prevent unsafe workarounds.
• Educate teams that ratchet “tightness” is not a reliable measure of safe tissue pressure.
• Confirm instrument integrity after any drop or suspected contamination event.
• Document and quarantine any clamp involved in a breakage or retained-item concern.
• Use multidisciplinary review to align clamp selection with specialty needs and protocols.

If you are looking for contributions and suggestion for this content please drop an email to contact@myhospitalnow.com